HF Advisory Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Sell |
5,384
-441
| -8% | -$172K | 0.83% | 43 |
|
|
2025
Q1 | $2.53M | Buy |
5,825
+755
| +15% | +$328K | 1.11% | 26 |
|
|
2024
Q4 | $1.87M | Buy |
5,070
+1,339
| +36% | +$494K | 0.86% | 40 |
|
|
2024
Q3 | $1.94M | Buy |
3,731
+415
| +13% | +$216K | 0.9% | 38 |
|
|
2024
Q2 | $1.8M | Buy |
3,316
+333
| +11% | +$180K | 0.93% | 36 |
|
|
2024
Q1 | $1.55M | Buy |
2,983
+21
| +0.7% | +$10.9K | 0.87% | 42 |
|
|
2023
Q4 | $1.4M | Buy |
2,962
+665
| +29% | +$314K | 0.89% | 37 |
|
|
2023
Q3 | $1.02M | Buy |
2,297
+440
| +24% | +$196K | 0.76% | 50 |
|
|
2023
Q2 | $825K | Buy |
1,857
+21
| +1% | +$9.33K | 0.65% | 59 |
|
|
2023
Q1 | $844K | Buy |
1,836
+225
| +14% | +$103K | 0.75% | 48 |
|
|
2022
Q4 | $826K | Buy |
+1,611
| New | +$826K | 0.84% | 39 |
|